M. Pehlivan And M. EKENEL, "The use of bevacizumab in primary malignant tumors of the central nervous system: A single-center experience," Medicine , vol.102, no.30, 2023
Pehlivan, M. And EKENEL, M. 2023. The use of bevacizumab in primary malignant tumors of the central nervous system: A single-center experience. Medicine , vol.102, no.30 .
Pehlivan, M., & EKENEL, M., (2023). The use of bevacizumab in primary malignant tumors of the central nervous system: A single-center experience. Medicine , vol.102, no.30.
Pehlivan, Metin, And Meltem EKENEL. "The use of bevacizumab in primary malignant tumors of the central nervous system: A single-center experience," Medicine , vol.102, no.30, 2023
Pehlivan, Metin And EKENEL, Meltem. "The use of bevacizumab in primary malignant tumors of the central nervous system: A single-center experience." Medicine , vol.102, no.30, 2023
Pehlivan, M. And EKENEL, M. (2023) . "The use of bevacizumab in primary malignant tumors of the central nervous system: A single-center experience." Medicine , vol.102, no.30.
@article{article, author={Metin Pehlivan And author={Meltem EKENEL}, title={The use of bevacizumab in primary malignant tumors of the central nervous system: A single-center experience}, journal={Medicine}, year=2023}